Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Pharmacogenetic interaction between dexamethasone and Cd36-deficient segment of spontaneously hypertensive rat chromosome 4 affects triacylglycerol and cholesterol distribution into lipoprotein fractions

M. Krupková, L. Sedová, F. Liska, D. Krenová, V. Kren, O. Seda,

. 2010 ; 9 () : 38. [pub] 20100416

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc12025784

Dexamethasone (DEX) is known to induce diabetes and dyslipidemia. We have compared fasting triacylglycerol and cholesterol concentrations across 20 lipoprotein fractions and glucose tolerance in control (standard diet) and DEX-treated 7-month-old males of two rat strains, Brown Norway (BN) and congenic BN.SHR-(Il6-Cd36)/Cub (BN.SHR4). These two inbred strains differ in a defined segment of chromosome 4, originally transferred from the spontaneously hypertensive rat (SHR) including the mutant Cd36 gene, a known target of DEX. Compared to BN, the standard-diet-fed BN.SHR4 showed higher cholesterol and triacylglycerol concentrations across many lipoprotein fractions, particularly in small VLDL and LDL particles. Total cholesterol was decreased by DEX by more than 21% in BN.SHR4 contrasting with the tendency to increase in BN (strain*DEX interaction p = 0.0017). Similar pattern was observed for triacylglycerol concentrations in LDL. The LDL particle size was significantly reduced by DEX in both strains. Also, while control BN and BN.SHR4 displayed comparable glycaemic profiles during oral glucose tolerance test, we observed a markedly blunted DEX induction of glucose intolerance in BN.SHR4 compared to BN. In summary, we report a pharmacogenetic interaction between limited genomic segment with mutated Cd36 gene and dexamethasone-induced glucose intolerance and triacylglycerol and cholesterol redistribution into lipoprotein fractions.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12025784
003      
CZ-PrNML
005      
20121207122754.0
007      
ta
008      
120817e20100416enk f 000 0#eng||
009      
AR
024    7_
$a 10.1186/1476-511x-9-38 $2 doi
035    __
$a (PubMed)20398376
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Krupková, Michaela $u Institute of Biology and Medical Genetics, Charles University, General Teaching Hospital, Prague, Czech Republic.
245    10
$a Pharmacogenetic interaction between dexamethasone and Cd36-deficient segment of spontaneously hypertensive rat chromosome 4 affects triacylglycerol and cholesterol distribution into lipoprotein fractions / $c M. Krupková, L. Sedová, F. Liska, D. Krenová, V. Kren, O. Seda,
520    9_
$a Dexamethasone (DEX) is known to induce diabetes and dyslipidemia. We have compared fasting triacylglycerol and cholesterol concentrations across 20 lipoprotein fractions and glucose tolerance in control (standard diet) and DEX-treated 7-month-old males of two rat strains, Brown Norway (BN) and congenic BN.SHR-(Il6-Cd36)/Cub (BN.SHR4). These two inbred strains differ in a defined segment of chromosome 4, originally transferred from the spontaneously hypertensive rat (SHR) including the mutant Cd36 gene, a known target of DEX. Compared to BN, the standard-diet-fed BN.SHR4 showed higher cholesterol and triacylglycerol concentrations across many lipoprotein fractions, particularly in small VLDL and LDL particles. Total cholesterol was decreased by DEX by more than 21% in BN.SHR4 contrasting with the tendency to increase in BN (strain*DEX interaction p = 0.0017). Similar pattern was observed for triacylglycerol concentrations in LDL. The LDL particle size was significantly reduced by DEX in both strains. Also, while control BN and BN.SHR4 displayed comparable glycaemic profiles during oral glucose tolerance test, we observed a markedly blunted DEX induction of glucose intolerance in BN.SHR4 compared to BN. In summary, we report a pharmacogenetic interaction between limited genomic segment with mutated Cd36 gene and dexamethasone-induced glucose intolerance and triacylglycerol and cholesterol redistribution into lipoprotein fractions.
650    _2
$a zvířata $7 D000818
650    _2
$a antigeny CD36 $x nedostatek $x genetika $7 D018955
650    _2
$a cholesterol $x metabolismus $7 D002784
650    _2
$a chromozomy $x metabolismus $7 D002875
650    _2
$a dexamethason $x farmakologie $7 D003907
650    _2
$a omezení příjmu potravy $7 D005215
650    _2
$a porucha glukózové tolerance $7 D018149
650    _2
$a lipoproteiny $x chemie $7 D008074
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mutace $7 D009154
650    _2
$a farmakogenetika $7 D010597
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani inbrední SHR $7 D011918
650    _2
$a triglyceridy $x metabolismus $7 D014280
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Sedová, Lucie
700    1_
$a Liska, Frantisek
700    1_
$a Krenová, Drahomíra
700    1_
$a Kren, Vladimír
700    1_
$a Seda, Ondrej
773    0_
$w MED00008241 $t Lipids in health and disease $x 1476-511X $g Roč. 9(20100416), s. 38
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20398376 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120817 $b ABA008
991    __
$a 20121207122829 $b ABA008
999    __
$a ok $b bmc $g 947826 $s 783130
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 9 $d 38 $e 20100416 $i 1476-511X $m Lipids in health and disease $n Lipids Health Dis $x MED00008241
LZP    __
$a Pubmed-20120817/10/03

Find record

Citation metrics

Archiving options